Quick Answer
MUSTANG BIO, INC. reported Cash And Cash Equivalents At Carrying Value of $17.27 million for the year ending 2025.
- MUSTANG BIO, INC. showed an increase of +152.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from MUSTANG BIO, INC.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2015: $0.00 | Q2 2016: $0.00 | Q3 2016: $11.12 million | Q4 2016: $27.50 million | Q2 2017: $53.79 million | Q3 2017: $33.21 million | Q3 2019: $72.79 million | Q1 2020: $55.81 million | Q2 2020: $85.36 million | Q3 2020: $75.25 million | Q1 2021: $129.37 million | Q2 2021: $129.92 million | Q3 2021: $120.88 million | Q1 2022: $122.22 million | Q2 2022: $107.37 million | Q3 2022: $91.36 million | Q1 2023: $58.10 million | Q2 2023: $15.39 million | Q3 2023: $9.56 million | Q1 2024: $1.34 million | Q2 2024: $4.27 million | Q3 2024: $3.53 million | Q1 2025: $14.23 million | Q2 2025: $12.66 million | Q3 2025: $18.98 million.
- Over the full 8 years of available data (2018 to 2025), MUSTANG BIO, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 4.8%.
- Historical annual values: Fiscal year 2025: $17.27 million | Fiscal year 2024: $6.84 million | Fiscal year 2023: $6.23 million | Fiscal year 2022: $75.66 million | Fiscal year 2021: $109.62 million | Fiscal year 2020: $97.80 million | Fiscal year 2019: $61.41 million | Fiscal year 2018: $16.47 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: